Targeted Therapies in Oncology

May 2017
Volume: 6
Issue: 5

April 2017
Volume: 6
Issue: 4

March 2017
Volume: 6
Issue: 3

February 2017
Volume: 6
Issue: 2

January 2017
Volume: 6
Issue: 1

November 2016
Volume: 5
Issue: 8

October 2016
Volume: 5
Issue: 7

September 2016
Volume: 5
Issue: 6

July 2016
Volume: 5
Issue: 5

May 2016
Volume: 5
Issue: 4

April 2016
Volume: 5
Issue: 3

March 2016
Volume: 6
Issue: 2

January 2016
Volume: 5
Issue: 1

November 2015
Volume: 4
Issue: 8

October 2015
Volume: 4
Issue: 7

September 2015
Volume: 4
Issue: 6

July 2015
Volume: 4
Issue: 5

May 2015
Volume: 4
Issue: 4

April 2015
Volume: 4
Issue: 2

November 2014
Volume: 3
Issue: 6

September 2014
Volume: 3
Issue: 5

July 2014
Volume: 3
Issue: 4

May 2014
Volume: 3
Issue: 3

March 2014
Volume: 3
Issue: 2

January 2014
Volume: 3
Issue: 1

November 2013
Volume: 2
Issue: 6

September 2013
Volume: 2
Issue: 5

July 2013
Volume: 2
Issue: 4

May 2013
Volume: 2
Issue: 3

March 2013
Volume: 2
Issue: 2
Advertisement
Advertisement
Trending on Targeted Onc
1
Galinpepimut-S Improves Overall Survival in Phase 3 REGAL Trial in AML
2
FDA Approves Neladalkib for Previously Treated Advanced ALK-Positive NSCLC
3
FDA Fast Tracks Elticertinib for Previously Treated EGFR Exon 20 NSCLC
4
Oncologists Weigh Age and Drug Interactions in mHSPC Treatment Selection
5
